JBT Marel (JBTM) Business Combination summary
Event summary combining transcript, slides, and related documents.
Business Combination summary
8 Jul, 2026Deal rationale and strategic fit
The combination creates a leading global food and beverage technology solutions provider, leveraging complementary strengths, technologies, and minimal overlap to enhance customer value, operational efficiency, and innovation.
Shared purpose and vision, with aligned values focused on sustainability, innovation, operational excellence, and customer-centricity.
Enhanced scale, broader integrated solutions, and global reach will improve customer engagement, service levels, and profitable growth.
The combined company will offer a unique, end-to-end portfolio in poultry and pet food processing, standing out in the competitive landscape.
Headquarters will be in Chicago, with a European HQ and technology center in Iceland.
Financial terms and conditions
Voluntary takeover offer for all outstanding shares, with Marel shareholders able to elect all cash (€3.60/share), all JBT stock (0.0407 JBT shares/share), or a mix (€1.26 cash + 0.0265 JBT shares/share), subject to proration (approx. 65% stock, 35% cash).
Marel shareholders to receive about €950 million in cash and hold roughly 38% of the combined company.
Total equity value of ~€2.7B and enterprise value of ~€3.5B including Marel's net debt.
JBT shares issued will be listed on NYSE and, pending approval, on Nasdaq Iceland.
Pro forma net leverage expected to be <3.5x at year-end 2024 and well below 3.0x by year-end 2025, with cash EPS accretion in the first full year post-close and double-digit ROIC within five years.
Synergies and expected cost savings
Targeting annual run-rate cost savings of ~$70 million within 12 months post-close, growing to over $125 million by year three.
Cost of goods sold synergies to exceed $55 million by 2027, with $25–35 million from direct material savings and $15–25 million from logistics and indirect spend.
Operating expense savings of over $70 million by year three, mainly from streamlining and eliminating redundancies.
Revenue synergies of over $75 million by year three, driven by integrated solutions, cross-selling, and geographic expansion.
Cost savings expected from supplier consolidation, logistics efficiencies, plant optimization, and back-office rationalization.
Latest events from JBT Marel
- Q1 2025 revenue hit $854M, but one-time charges drove a $173M net loss; outlook cautious.JBTM
Q1 20258 Jul 2026 - $3.9B TTM revenue, 16.2% EBITDA margin, and strong recurring revenue drive growth and resilience.JBTM
Investor presentation31 May 2026 - All director nominees and proposals were approved, with no questions from stockholders.JBTM
AGM 202614 May 2026 - Q1 2026 saw 10% revenue growth, $45M net income, and strong Protein Solutions margin gains.JBTM
Q1 202612 May 2026 - 2025 saw record revenue and synergy gains, with 2026 set for further growth and margin expansion.JBTM
Q4 202511 Apr 2026 - Annual meeting to elect directors, approve pay, and ratify auditor, with board support.JBTM
Proxy filing1 Apr 2026 - Proxy details director elections, pay-for-performance, and strong ESG focus after a transformative merger.JBTM
Proxy filing1 Apr 2026 - Targeting 5–7% organic growth and >20% EBITDA margin by 2028 through digital integration.JBTM
Investor Day 202626 Mar 2026 - Merger forms a global food tech leader, targeting $125M+ synergies and closing by end-2024.JBTM
M&A Announcement3 Feb 2026